Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 123INDUSTRY 48NIH 21NETWORK 19OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 13Thoracic 12Gynecologic 9Head & Neck 8Breast 3Other solid neoplasm 1NET 1Genitourinary 1Endocrine 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 3Zoledronic Acid 3Saline Solution 3Gemcitabine 3enzalutamide 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 2Androgen Antagonists 2Abiraterone Acetate 2veliparib 1toripalimab 1darolutamide 1bemarituzumab 1avelumab 1apatorsen 1apalutamide 1anlotinib 1aldesleukin 1abiraterone 1Watchful Waiting 1Videotape Recording 1Urination 1Ultrasound, High-Intensity Focused, Transrectal 1Transurethral Resection of Prostate 1Tacrolimus 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Cisplatin × Genitourinary × Clear all
NCT06358599 2024-04-10

The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy

Ankara Etlik City Hospital

Completed
221 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡